Afri Grow Partners with Gamma Diagnostics

We are thrilled to announce an exclusive distribution agreement and the SAHPRA approval of GammaCoeur™ CVD Risk ELISA Test System with Afri Grow (Pty) Ltd.

Our aim is to introduce GammaCoeur™, a cutting-edge diagnostic blood test that revolutionizes the way healthcare professionals diagnose cardiovascular risk and potentially various other medical conditions. The efficacy and accuracy of this kit holds immense potential in improving patient outcomes and reducing the burden on healthcare systems across Africa.

This partnership marks a significant milestone in the advancement of healthcare in the African continent, with an initial focus on South Africa.

For further information please read our press release.

Previous
Previous

Gamma Diagnostics awarded a grant to develop Antisense Oligonucleotides

Next
Next

New publication of GPF as a biomarker of Covid-19